← Leaderboards
James Ivan Mullins
University Of Washington
$34,901,920
Attributed
$38,396,302
Total exposure
22
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$58,888,191 · 23
By mechanism
P01$26,459,651 · 5
R01$16,741,395 · 7
R37$5,928,522 · 1
P30$3,188,552 · 4
R61$3,080,537 · 1
R33$1,566,313 · 1
Top collaborators
- Deborah L. Fuller4 shared
- Zhijun Duan3 shared
Most similar at University Of Washington
Same institution · by research overlap
- David Baker$22,630,205
- Margaret A Hannon$27,495,073
- Nancy Logan Haigwood$37,253,957
- David Veesler$16,345,259
- Alexander L Greninger$4,283,708
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsVirusViralInfectionHiv-1GenesCohortAcquired Immunodeficiency SyndromeCellsCd4 Positive T LymphocytesBioinformaticsSitePhylogenetic AnalysisLinkGeneticResearch PersonnelAntiretroviral TherapyLaboratoriesEvolutionVirus GeneticsDisease ProgressionTechnologyT-LymphocyteBiological
Grant awards (90)
Core H: Retrovirology and Molecular Data Science$448,476
P30 · FY2022 · AI · contact PI
Core H: Retrovirology and Molecular Data Science$394,106
P30 · FY2021 · AI · contact PI
Impact of Methamphetamine Use on the HIV Nucleome in Individuals on Antiretroviral Therapy$1,014,569
R61 · FY2020 · DA · contact PI
Ex Vivo Detection and Analysis of Non-inducible Latent HIV$516,958
R33 · FY2020 · AI · contact PI
Core H: Retrovirology and Molecular Data Science$350,203
P30 · FY2020 · AI · contact PI
Impact of Methamphetamine Use on the HIV Nucleome in Individuals on Antiretroviral Therapy$1,019,871
R61 · FY2019 · DA · contact PI
Role of proviral loci in HIV latency$833,533
R01 · FY2019 · AI · contact PI
Ex Vivo Detection and Analysis of Non-inducible Latent HIV$522,571
R33 · FY2019 · AI · contact PI
Core H: Retrovirology and Molecular Data Science$355,083
P30 · FY2019 · AI · contact PI
Impact of Methamphetamine Use on the HIV Nucleome in Individuals on Antiretroviral Therapy$1,046,097
R61 · FY2018 · DA · contact PI
Mechanisms of Formation and Persistence of Active HIV Reservoirs$853,171
R01 · FY2018 · AI · contact PI
Role of proviral loci in HIV latency$830,592
R01 · FY2018 · AI · contact PI
Ex Vivo Detection and Analysis of Non-inducible Latent HIV$526,784
R33 · FY2018 · AI · contact PI
Core H: Retrovirology and Molecular Data Science$319,867
P30 · FY2018 · AI · contact PI
Mechanisms of Formation and Persistence of Active HIV Reservoirs$852,807
R01 · FY2017 · AI · contact PI
Role of proviral loci in HIV latency$852,198
R01 · FY2017 · AI · contact PI
Ex Vivo Detection and Analysis of Non-inducible Latent HIV$242,050
R21 · FY2017 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,076
R01 · FY2016 · AI
Role of proviral loci in HIV latency$915,358
R01 · FY2016 · AI · contact PI
Mechanisms of Formation and Persistence of Active HIV Reservoirs$872,329
R01 · FY2016 · AI · contact PI
Ex Vivo Detection and Analysis of Non-inducible Latent HIV$236,433
R21 · FY2016 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,075
R01 · FY2015 · AI
Mechanisms of Formation and Persistence of Active HIV Reservoirs$872,419
R01 · FY2015 · AI · contact PI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION$2,462,710
P01 · FY2014 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,076
R01 · FY2014 · AI
Establishment of HIV infection and ensuing HostiVirus interactions$888,687
P01 · FY2014 · AI · contact PI
Mechanisms of Formation and Persistence of Active HIV Reservoirs$805,799
R01 · FY2014 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$674,477
R37 · FY2014 · AI · contact PI
Program Administration and Data Management$354,161
P01 · FY2014 · AI · contact PI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION$2,316,771
P01 · FY2013 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$959,000
R01 · FY2013 · AI
Establishment of HIV infection and ensuing HostiVirus interactions$678,220
P01 · FY2013 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$635,513
R37 · FY2013 · AI · contact PI
Program Administration and Data IVIanagement$296,057
P01 · FY2013 · AI · contact PI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION$2,464,650
P01 · FY2012 · AI · contact PI
Establishment of HIV infection and ensuing HostiVirus interactions$807,701
P01 · FY2012 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$679,593
R37 · FY2012 · AI · contact PI
Program Administration and Data IVIanagement$358,099
P01 · FY2012 · AI · contact PI
Computational Biology$288,952
P30 · FY2012 · AI · contact PI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION$2,502,001
P01 · FY2011 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$685,492
R37 · FY2011 · AI · contact PI
Establishment of HIV infection and ensuing HostiVirus interactions$605,466
P01 · FY2011 · AI · contact PI
Program Administration and Data IVIanagement$352,167
P01 · FY2011 · AI · contact PI
Computational Biology$306,158
P30 · FY2011 · AI · contact PI
Management and Retrieval of Multidisciplinary HIV Research Data$246,510
R21 · FY2011 · AI · contact PI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION$2,586,625
P01 · FY2010 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$694,859
R37 · FY2010 · AI · contact PI
Establishment of HIV infection and ensuing HostiVirus interactions$668,322
P01 · FY2010 · AI · contact PI
Virus production from HIV reservoirs$495,102
RC1 · FY2010 · AI · contact PI
Program Administration and Data IVIanagement$364,242
P01 · FY2010 · AI · contact PI
Management and Retrieval of Multidisciplinary HIV Research Data$203,606
R21 · FY2010 · AI · contact PI
Computational Biology$162,093
P30 · FY2010 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$540,056
R37 · FY2009 · AI · contact PI
Virus production from HIV reservoirs$499,520
RC1 · FY2009 · AI · contact PI
Computational Biology$173,306
P30 · FY2009 · AI · contact PI
Immunology and Virology of Acute HIV Infection$124,998
P01 · FY2009 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$528,578
R37 · FY2008 · AI · contact PI
Computational Biology$171,801
P30 · FY2008 · AI · contact PI
Immunology and Virology of Acute HIV Infection$1,809,191
P01 · FY2007 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$523,125
R37 · FY2007 · AI · contact PI
HIV-1 and Host Cell Changes in Disease Progression$464,875
R01 · FY2007 · AI · contact PI
Immunology and Virology of Acute HIV Infection$1,801,614
P01 · FY2006 · AI · contact PI
Occurrence and Outcome of Dual HIV-1 Infection$523,047
R37 · FY2006 · AI · contact PI
HIV-1 and Host Cell Changes in Disease Progression$470,874
R01 · FY2006 · AI · contact PI
Immunology and Virology of Acute HIV Infection$1,783,778
P01 · FY2005 · AI
HIV-1 and Host Cell Changes in Disease Progression$468,453
R01 · FY2005 · AI
Occurrence and Outcome of Dual HIV-1 Infection$443,782
R37 · FY2005 · AI
Immunology and Virology of Acute HIV Infection$1,805,181
P01 · FY2004 · AI
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTION$485,557
R01 · FY2004 · AI
HIV-1 and Host Cell Changes in Disease Progression$472,842
R01 · FY2004 · AI
Core-Genomics$40,059
P30 · FY2004 · AI
Immunology and Virology of Acute HIV Infection$834,370
P01 · FY2003 · AI
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTION$507,865
R01 · FY2003 · AI
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTION$493,069
R01 · FY2002 · AI
ANTIVIRAL THERAPY AND COMPARTMENTS OF HIV IN VIVO$237,793
R01 · FY2002 · AI
CORE--MOLECULAR BIOLOGY$0
P01 · FY2002 · AI
CORE--MOLECULAR DIVERSITY$0
P30 · FY2002 · AI
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTION$478,735
R01 · FY2001 · AI
ANTIVIRAL THERAPY AND COMPARTMENTS OF HIV IN VIVO$230,867
R01 · FY2001 · AI
COALESCENT METHODS FOR MEASURABLY EVOLVING POPULATIONS$100,284
R01 · FY2001 · GM
IMPACT OF T CELL THERAPY ON HIV POPULATION DYNAMICS$0
P01 · FY2001 · AI
CORE--MOLECULAR BIOLOGY$0
P01 · FY2001 · AI
NATURAL HISTORY OF SIVMAC BK28 &H824 INFECTION IN MACAQUES$0
P51 · FY2001 · RR
CORE--MOLECULAR DIVERSITY$0
P30 · FY2001 · AI
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTION$412,097
R01 · FY2000 · AI
CORE--MOLECULAR BIOLOGY$343,350
P01 · FY2000 · AI
IMPACT OF T CELL THERAPY ON HIV POPULATION DYNAMICS$251,290
P01 · FY2000 · AI
ANTIVIRAL THERAPY AND COMPARTMENTS OF HIV IN VIVO$224,142
R01 · FY2000 · AI
CORE--MOLECULAR DIVERSITY$178,448
P30 · FY2000 · AI
COALESCENT METHODS FOR MEASURABLY EVOLVING POPULATIONS$97,509
R01 · FY2000 · GM